CVS Health is preparing to split its healthcare empire into two publicly traded companies, separating its nearly 9,000 retail pharmacies from its insurance and pharmacy benefit management operations. The proposed restructuring is reportedly targeted for early 2028, and would reverse years of expansion that transformed CVS into one of America's largest healthcare conglomerates.
The breakup was first reported by the Financial Times on Nov. 4.
CVS Pharmacy Breakup Would Create Two Public Companies
Under the reported plan, CVS will establish two independently traded businesses. The first, CVS Pharmacy, will operate approximately 9,000 retail pharmacies alongside its mail-order pharmacy services, MinuteClinic locations and Health100 digital health platform.
The second company will keep the CVS Health name and include health insurer Aetna, pharmacy benefit manager CVS Caremark, Oak Street Health, Signify Health and specialty pharmaceutical operations.
Current CEO David Joyner will reportedly continue leading CVS Health, while existing shareholders will receive shares in both companies.
CEO David Joyner
The proposed separation is a big reversal of CVS's approximately $78 billion acquisition of Aetna in 2018, which was intended to combine insurance, prescription services and retail healthcare under one organization.
Although early 2028 has been identified as a potential completion date, the transaction's structure and timing could still change.
Why Is CVS Health Breaking Up?
The restructuring comes amid growing regulatory scrutiny of healthcare companies that simultaneously control pharmacies, insurers and pharmacy benefit managers. Lawmakers have raised concerns that this business model gives large healthcare conglomerates excessive influence over prescription drug pricing and competition.
Meanwhile, CVS also faced some financial challenges in several divisions. Aetna has struggled with rising medical expenses, while its retail pharmacy business faces competition from online prescription services and declining store traffic.
Joyner, however, made it clear that regulatory pressure was not driving the decision. He instead argues that independent management teams could operate more effectively.
CVS Stock Rises as Investors React to Breakup Plans
CVS stock gained approximately 3.3% during Tuesday's regular trading session before climbing more in after-hours trading following the initial reports.
Investors could benefit if the separation allows each business to pursue independent growth strategies and receive valuations more closely aligned with its operations. However, analysts have warned that splitting CVS could eliminate existing operational efficiencies and introduce more corporate expenses.
Investors are now waiting for CVS's third-quarter earnings announcement on Nov. 4.
